It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
Scientists found that healthy women can carry genetic changes in their breast cells that are thought to be characteristic of invasive breast cancer. Most cancer cells have too many or too few ...